| Patents for C07D 239 - Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings (42,619) |
|---|
| 06/14/2006 | EP1667955A2 Cycloalkylidene compounds as modulators of the estrogen receptor |
| 06/14/2006 | EP1667685A1 Quinazoline potassium channel inhibitors |
| 06/14/2006 | EP1309564B1 Arylethene-sulfonamides, their preparation and their use as endothelin antagonists |
| 06/14/2006 | EP1102742B1 Compounds and compositions for delivering active agents |
| 06/14/2006 | DE4410606B4 Cyanopyrimidin-Derivate und flüssigkristallines Medium Cyanopyrimidine derivatives and liquid crystalline medium |
| 06/14/2006 | DE4407802B4 Azoverbindungen und Zwischenprodukte, deren Herstellung und Verwendung Azo compounds and intermediates, their preparation and use |
| 06/14/2006 | CN1788001A 2, 4- di (phenylamino) pyrimidines useful in the treatment of neoplastic diseases, inflammatory and immune system disorders |
| 06/14/2006 | CN1259313C Process for preparation of azoxystrobin and analogues thereof |
| 06/14/2006 | CN1259307C Acylated indanyl amines and their use as pharmaceuticals |
| 06/13/2006 | US7060827 Intermediates useful for making 2,4-pyrimidinediamine compounds |
| 06/13/2006 | US7060826 Central nervous system disorders; Alzheimer's disease; huntington's disease; Parkinson's disease; attention deficit disorders; schizophrenia; Tourette's syndrome |
| 06/13/2006 | US7060825 Process for synthesizing 6-quinazolinyl-ethyl-benzoyl and related antifolates |
| 06/13/2006 | US7060706 Quinazolinones |
| 06/13/2006 | US7060705 2-(saturated N-heterocycylalkyl) quinazolinone compounds, e.g., 3-benzyl-2-[1-(4-methylpiperazin-1-yl)propyl]quinazolin-4(3H)-one, used to treat cancer, especially histiocytic lymphoma, lung adenocarcinoma, small cell lung cancer, pancreatic cancer, glioblastoma and breast carcinoma |
| 06/13/2006 | US7060700 Amide derivatives useful as inhibitors of the production of cytokines |
| 06/13/2006 | CA2260777C Pentafluorobenzenesulfonamides and analogs |
| 06/13/2006 | CA2238723C Arylethenesulfonamide derivatives and drug composition containing the same |
| 06/08/2006 | WO2006060730A2 Potassium salt of an hiv integrase inhibitor |
| 06/08/2006 | WO2006059234A2 Bicyclic amides as kinase inhibitors |
| 06/08/2006 | WO2006034512A3 Phenyl-substituted quinoline and quinazoline compounds for the treatment of diabetes |
| 06/08/2006 | WO2006010749A3 Substituted propenyl piperazine derivatives as novel inhibitors of histone deacetylase |
| 06/08/2006 | US20060122268 Such as N1-(1-cyanocyclopropyl)-4-fluoro-N2-((1S)-2,2,2-trifluoro-1-(4' -(methylsulfonyl)-1,1'-biphenyl-4-yl) ethyl)-L-leucinamide; for treating osteoporosis and other bone loss disorders |
| 06/08/2006 | US20060122239 Lipid diseases; metabolism diosrders; antiproliferative agents |
| 06/08/2006 | US20060122231 Such as N-(4-tert-butylphenyl)-4-(2-pyridinyl)benzamide for treatment of urinary incontinence, pain, inflammatory thermal hyperalgesia, and/or bladder overactivity |
| 06/08/2006 | US20060122209 Process for preparing trisubstituted pyrimidine compounds |
| 06/08/2006 | US20060122204 Gonadotropin-releasing hormone receptor antagonists and methods relating thereto |
| 06/08/2006 | US20060122203 2-Hydroxymethylcyclopropylidenemethylpurines and - pyrimidines as antiviral agents |
| 06/08/2006 | US20060122202 For example, 3-[2(R)-{hydroxycarbonylpropyl-amino}-2-phenylethyl]-5-(2-fluoro-3-methoxyphenyl)-1-[2-fluoro-6-(trifluoromethyl)benzyl]-6-methyl-pyrimidine-2,4(1H,3H)-dione; use in treating prostate cancer, benign prostatic hypertrophy, breast cancer and endometriosis |
| 06/08/2006 | US20060122201 Uracil-thioether |
| 06/08/2006 | US20060122062 2,2,2-trifluoro-N-[5-methyl-1-(3-trifluoromethylphenyl)-2(1H)-pyridinylidene]-acetamide; herbicides; 1-phenylazinethione and 1-phenylchloroazinium intermediates; 1-phenylpyridones: 5-methyl-1-(3-trifluoromethyl-phenyl)-2(1H)-pyridinone |
| 06/08/2006 | US20060120958 Solid-phase fluorination of uracil and cytosine |
| 06/08/2006 | DE4215277B4 Benzolderivate und ihre Verwendung für ein flüssigkristallines Medium Benzene derivatives and their use for a liquid-crystalline medium |
| 06/08/2006 | DE102004044680B3 Alkyliden-Tetrahydronaphthalinderivate, Verfahren zu ihrer Herstellung und ihre Verwendung als Entzündungshemmer sowie diese enthaltende pharmazeutische Präparate Alkylidene-tetrahydronaphthalene derivatives, processes for their preparation and their use as anti-inflammatories, as well as pharmaceutical compositions containing them |
| 06/08/2006 | CA2738383A1 Bicyclic amides as kinase inhibitors |
| 06/07/2006 | EP1666468A1 Crf antagonists and heterobicyclic compounds |
| 06/07/2006 | EP1664035A1 2,4 di (hetero) -arylamino-pyrimidine derivatives as zap-70 and/or syk inhibitors |
| 06/07/2006 | EP1663994A1 Condensed pyrimidine compounds as inhibitors of voltage-gated ion channels |
| 06/07/2006 | EP1663993A1 Guanidine derivatives |
| 06/07/2006 | EP1663992A1 2,4-di (phenylamino) pyrimidines useful in the treatment of proliferative disorders |
| 06/07/2006 | EP1663991A1 Selective synthesis of cf3-substituted pyrimidines |
| 06/07/2006 | EP1663990A1 Polymorphic forms of a known antihyperlipemic agent |
| 06/07/2006 | EP1663989A1 CRYSTALLINE FORM OF BIS (E)-7- 4-(4-FLUOROPHENYL)-6-IS OPROPYL-2- METHYL(METHYLSULFONYL)AMINO PYRIMIDIN-5-YL&r sqb;(3R,5S)-3,5-DIHYDROXYHEPT-6 -ENOICACID CALCIUM SALT |
| 06/07/2006 | EP1663970A1 Matrix metalloproteinase inhibitors |
| 06/07/2006 | EP1663962A2 Compositions and methods for the treatment of disease associated with trp-p8 expression |
| 06/07/2006 | EP1663241A1 5-arylpyrimidines as anticancer agents |
| 06/07/2006 | EP1663237A2 Fused ring heterocycles as potassium channel modulators |
| 06/07/2006 | EP1663234A1 Piperazine derivatives for the treatment of hiv infections |
| 06/07/2006 | EP1663204A2 C-kit modulators and methods of use |
| 06/07/2006 | EP1311478B1 Novel (thio)urea compounds and the pharmaceutical compositions containing the same |
| 06/07/2006 | CN1784391A Quinazolines useful as modulators of ion channels |
| 06/07/2006 | CN1784390A Substituted dihydrochinazolines having antiviral properties |
| 06/07/2006 | CN1784389A Pyrimidine compounds and pests controlling composition containing the same |
| 06/07/2006 | CN1781890A 糖皮质激素受体调制剂 Glucocorticoid receptor modulators |
| 06/06/2006 | US7057067 Reacting a benzoic acid with a halogenating agent in presence of palladium catalyst to form halogenated benzoic acid or derivatives |
| 06/06/2006 | US7057043 Processes for preparing aminophenylsulfonylureas, and intermediates therefor |
| 06/06/2006 | US7056937 Sulfonylquinoxalone derivatives as bradykinin antagonists |
| 06/06/2006 | US7056932 Heterocyclyl substituted 1-alkoxy acetic acid amides |
| 06/06/2006 | US7056928 anti-inflammatory, anti-pyretic and analgesic properties, without the potential side effects associated with inhibition of COX-1 |
| 06/06/2006 | US7056927 Gonadotropin-releasing hormone receptor antagonists and methods relating thereto |
| 06/06/2006 | US7056926 sulfonylurea derivatives, sulfonylthiourea derivatives, sulfonylguanidine derivatives, sulfonylcyanoguanidine derivatives, thioacylsulfonamide derivatives, and acylsulfonamide derivatives; effective for prevention and treatment of cardiovascular diseases, particularly those diseases related to thrombosis |
| 06/06/2006 | US7056925 Urea kinase inhibitors |
| 06/06/2006 | US7056922 Acylamino cyclopropane derivatives |
| 06/06/2006 | US7056911 for example, N-[(2,4-diaminopteridin-6-yl)methyl]-9,10-dihydrodibenz[b,f]azepine; may be useful for treatment or prophylaxis of diseases associated with parasitic infection such as pneumocystis pneumonia, toxoplasmosis, cryptosporidiosis, leischmaniasis and malaria |
| 06/06/2006 | US7056376 Printing an image on a substrate comprising applying thereto a formulation comprising a liquid medium and a compound containing azo groups and metallized 1,8-dihydroxynaphthyl group |
| 06/06/2006 | CA2352592C Quinazolinone compounds |
| 06/06/2006 | CA2232913C Process for the preparation of azide derivatives |
| 06/06/2006 | CA2163601C 2-aminobenzenesulfonic acid and 2-aminobenzenesulfonyle chloride derivatives |
| 06/06/2006 | CA2160366C Risperidone pamoate |
| 06/01/2006 | WO2006033844A3 4-arylspirocycloalkyl-2-aminopyrimidine carboxamide kcnq potassium channel modulators |
| 06/01/2006 | WO2006030211A3 Acyclic sulphonamides |
| 06/01/2006 | US20060116516 2-[[4-[[[4-(Aminosulfonyl)phenyl]methyl]amino]pyrido[2,3-d]pyrimidin-2-yl]amino]-4-methyl-5-thiazolecarboxylic acid, ethyl ester; 4-Methyl-2-[[4-[[[4-(methylsulfonyl)phenyl]methyl]amino]pyrido[2,3-d]pyrimidin-2-yl]amino]-5-thiazolecarboxylic acid, ethyl ester; Antiinflammatory agents; rheumatic diseases |
| 06/01/2006 | US20060116418 Materials and methods for treating hypercholesterolemia |
| 06/01/2006 | US20060116391 adding a solution of calcium chloride with a solution of water soluble an alkali metal or methylamine or ammonium salt of (E)-7-[4-(4-fluorophenyl)-6-isopropyl-2-[methyl(methylsulfonyl)amino]pyrimidin-5-yl](3R,5S)-3,5-dihydroxyhept-6-enoic acid; cost efficient; hypercholesterolemia, atherosclerosis |
| 06/01/2006 | US20060116390 Hepatitis c virus inhibitors |
| 06/01/2006 | US20060116388 CXCR3 antagonists |
| 06/01/2006 | US20060116377 Dialkylhydroxybenzoic acid derivatives containing metal chelating groups and their therapeutic uses |
| 06/01/2006 | US20060116366 Spirocyclic ureas, compositions containing such compounds and methods of use |
| 06/01/2006 | US20060116357 Aurora kinases inhibitors; antiproliferative agents; specially for solid and haematological tumors; 2-[[3-({4-[(5-{2-[(3-fluorophenyl)amino]-2-oxoethyl}-1H-pyrazol-3-yl)amino]-quinazolin-7-yl}oxy)propyl](ethyl)amino]ethyl dihydrogen phosphate |
| 06/01/2006 | US20060115815 Method and compositions for identifying anti-hiv therapeutic compounds |
| 06/01/2006 | US20060115425 Antagonists and/or inverse agonists of the Cannabinoid-1 receptor; useful in treatment of central nervous system disorders, psychological disorders, multiple sclerosis, as antiinflammatory agents |
| 06/01/2006 | DE4211694B4 Flüssigkristalline Verbindungen Liquid-crystalline compounds |
| 06/01/2006 | CA2588607A1 Carbazole, carboline and indole derivatives useful in the inhibition of vegf production |
| 05/31/2006 | EP1661569A1 Compounds effecting glucokinase |
| 05/31/2006 | EP1661568A1 Compounds effecting Glucokinase |
| 05/31/2006 | EP1661567A1 Compounds effecting Glucokinase |
| 05/31/2006 | EP1661563A1 Compound effecting Glucokinase |
| 05/31/2006 | EP1660503A1 Naphthalene carboxamides and their derivatives useful as new anti-angiogenic agents |
| 05/31/2006 | EP1660471A1 Derivatives of hydroxamic acid as metalloproteinase inhibitors |
| 05/31/2006 | EP1660458A1 2, 4-pyrimidinediamines useful in the treatment of neoplastic diseases, inflammatory and immune system disorders |
| 05/31/2006 | EP1660445A1 Lactams of alkylated acyclic diamine derivatives as modulators of chemokine receptor activity |
| 05/31/2006 | EP1660441A2 N-sulfonyl-alpha-amino-acid derivatives |
| 05/31/2006 | EP1660428A1 Ppar modulators |
| 05/31/2006 | EP1660427A1 Substituted arylalkanoic acid derivative and use thereof |
| 05/31/2006 | EP1660184A2 17-acetamido-4-azasteroid derivatives as androgen receptor modulators |
| 05/31/2006 | EP1660092A2 4-arylamino-quinazolines as activators of caspases and inducers of apoptosis |
| 05/31/2006 | EP1660091A1 Pyrimidine-2,4-dione derivatives as gonadotropin-releasing hormone receptor antagonists |
| 05/31/2006 | EP1660090A1 Quinazoline analogs as receptor tyrosine kinase inhibitors |
| 05/31/2006 | EP1659863A2 Pesticidally active phenol derivatives |
| 05/31/2006 | EP1527052B1 3-heterocyclyl substituted benzoic acid derivatives |
| 05/31/2006 | EP1420644B1 Substituted propargylamines |